Alliancebernstein L.P. Immuno Gen, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $15 Million - $36.2 Million	1,207,295 Added 401.74%	1,507,809 $44.7 Million
Q2 2023 Aug 15, 2023	BUY	$3.75 - $20.05 $44,437 - $237,592	11,850 Added 4.11%	300,514 $5.67 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $161,110 - $223,430	-35,409 Reduced 10.93%	288,664 $1.43 Million
Q3 2022 Nov 15, 2022	SELL	$4.48 - $6.47 $699,991 - $1.01 Million	-156,248 Reduced 32.53%	324,073 $1.55 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $603,719 - $1.1 Million	191,657 Added 66.39%	480,321 $2.16 Million

Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $3,408 - $5,984	800 Added 0.28%	288,664 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $601,383 - $949,552	-126,607 Reduced 30.55%	287,864 $2.14 Million
Q3 2021 Nov 10, 2021	BUY	$5.02 - $6.59 $635,567 - $834,340	126,607 Added 43.98%	414,471 $2.35 Million
Q3 2020 Nov 12, 2020	SELL	$3.45 - $4.89 $33,465 - $47,433	-9,700 Reduced 3.26%	287,864 $1.04 Million
Q2 2020 Aug 13, 2020	BUY	$3.32 - $5.34 $21,912 - $35,244	6,600 Added 2.27%	297,564 $1.37 Million
Q4 2019 Feb 18, 2020	SELL	$2.25 - $5.8 $62,325 - $160,660	-27,700 Reduced 8.69%	290,964 $1.49 Million
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $25,752 - $39,324	-11,600 Reduced 3.51%	318,664 $771,000
Q2 2019 Aug 14, 2019	BUY	$1.8 - $3.3 $195,480 - $358,380	108,600 Added 48.99%	330,264 $717,000
Q1 2019 May 14, 2019	SELL	$2.41 - $5.91 $279,029 - $684,259	-115,780 Reduced 34.31%	221,664 $601,000
Q4 2018 Feb 13, 2019	BUY	$3.94 - $9.7 $481,629 - $1.19 Million	122,241 Added 56.8%	337,444 $1.62 Million
Q3 2018 Nov 08, 2018	SELL	$8.6 - $11.26 $2,700 - $3,535	-314 Reduced 0.15%	215,203 $2.04 Million
Q2 2018 Aug 13, 2018	BUY	$9.52 - $12.15 $907,760 - $1.16 Million	95,353 Added 79.35%	215,517 $2.1 Million
Q1 2018 May 14, 2018	SELL	$6.7 - $12.95 $4,020 - $7,770	-600 Reduced 0.5%	120,164 $1.26 Million
Q4 2017 Feb 13, 2018	BUY	$5.07 - $7.92 $12,675 - $19,800	2,500 Added 2.11%	120,764 $774,000
Q3 2017 Nov 13, 2017	BUY	$5.4 - $8.47 $638,625 - $1 Million	118,264	118,264 $905,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account